82_FR_12499 82 FR 12458 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

82 FR 12458 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 41 (March 3, 2017)

Page Range12458-12459
FR Document2017-04078

Federal Register, Volume 82 Issue 41 (Friday, March 3, 2017) 
[Federal Register Volume 82, Number 41 (Friday, March 3, 2017)]
[Notices]
[Pages 12458-12459]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-04078]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorder 
and Stroke Special Emphasis Panel; BRAIN: Large Scale Recording and 
Neuromodulation.
    Date: March 27-28, 2017.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Shanta Rajaram, Ph.D., Scientific Review 
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience 
Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 
20892-9529, (301) 496-6033, rajarams@mail.nih.gov.

    Name of Committee: National Institute of Neurological Disorder 
and Stroke Special Emphasis Panel; Program Project Grant P01.
    Date: March 30, 2017.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Ana Olariu, Ph.D., Scientific Review Officer, 
Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 
Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529, 
(301) 496-9223, Ana.Olariu@nih.gov.

    Name of Committee: National Institute of Neurological Disorder 
and Stroke Special Emphasis Panel; Leveraging Existing Resources for 
Research on Lewy Body Dementia.
    Date: April 7, 2017.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Ernest Lyons, Ph.D., Scientific Review Officer, 
Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 
Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529, 
(301) 496-0182, lyonse@ninds.nih.gov.

    Name of Committee: National Institute of Neurological Disorder 
and Stroke Special Emphasis Panel; Training and Career Development 
Application Review.
    Date: April 10, 2017.
    Time: 1:30 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Elizabeth A. Webber, Ph.D., Scientific Review 
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience 
Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 
20892-9529, (301) 496-1719, webbere@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the

[[Page 12459]]

Neurosciences, National Institutes of Health, HHS)

    Dated: February 27, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04078 Filed 3-2-17; 8:45 am]
 BILLING CODE 4140-01-P

12458 Federal Register / Vol. 82, No. 41 / Friday, March 3, 2017 / Notices appropriate advisory committee meeting notify interested persons regarding their Name of Committee: National Institute of link, or call the advisory committee request to speak by March 14, 2017. Neurological Disorder and Stroke Special information line to learn about possible Persons attending FDA’s advisory Emphasis Panel; BRAIN: Large Scale committee meetings are advised that the Recording and Neuromodulation. modifications before coming to the Date: March 27–28, 2017. meeting. Agency is not responsible for providing Time: 8:00 a.m. to 12:00 p.m. access to electrical outlets. Agenda: To review and evaluate grant SUPPLEMENTARY INFORMATION: FDA is establishing a docket for applications. Agenda: The committees will discuss public comment on this meeting. The Place: Embassy Suites at the Chevy Chase safety issues associated with over-the- docket number is FDA–2017–N–0965. Pavilion, 4300 Military Road NW., counter analgesic combination products The docket will close on April 3, 2017. Washington, DC 20015. used for upset stomach (i.e., heartburn, Comments received on or before March Contact Person: Shanta Rajaram, Ph.D., nausea, fullness, belching, gas, acid 21, 2017, will be provided to the Scientific Review Officer, Scientific Review indigestion, and/or sour stomach) and committees. Comments received after Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, hangover indications under the Internal that date will be taken into MSC 9529, Bethesda, MD 20892–9529, (301) Analgesic and Antacid monographs in consideration by the Agency. 496–6033, rajarams@mail.nih.gov. 21 CFR part 343 and 21 CFR part 331, FDA welcomes the attendance of the Name of Committee: National Institute of respectively. The committees will also public at its advisory committee Neurological Disorder and Stroke Special be asked to discuss the hangover meetings and will make every effort to Emphasis Panel; Program Project Grant P01. indication under the Overindulgence, accommodate persons with disabilities. Date: March 30, 2017. Internal Analgesic, and Stimulant If you require accommodations due to a Time: 11:00 a.m. to 6:00 p.m. monographs in 21 CFR part 357 subpart disability, please contact Moon Hee V. Agenda: To review and evaluate grant J, 21 CFR part 343, and 21 CFR part 340, Choi at least 7 days in advance of the applications. respectively. meeting. Place: National Institutes of Health, FDA is committed to the orderly Neuroscience Center, 6001 Executive FDA intends to make background Boulevard, Rockville, MD 20852 (Virtual material available to the public no later conduct of its advisory committee Meeting). than 2 business days before the meeting. meetings. Please visit our Web site at Contact Person: Ana Olariu, Ph.D., If FDA is unable to post the background http://www.fda.gov/ Scientific Review Officer, Scientific Review material on its Web site prior to the AdvisoryCommittees/ Branch, NINDS/NIH/DHHS, Neuroscience meeting, the background material will AboutAdvisoryCommittees/ Center, 6001 Executive Blvd., Suite 3204, be made publicly available at the ucm111462.htm for procedures on MSC 9529, Bethesda, MD 20892–9529, (301) location of the advisory committee public conduct during advisory 496–9223, Ana.Olariu@nih.gov. meeting, and the background material committee meetings. Name of Committee: National Institute of will be posted on FDA’s Web site after Notice of this meeting is given under Neurological Disorder and Stroke Special the Federal Advisory Committee Act (5 Emphasis Panel; Leveraging Existing the meeting. Background material is U.S.C. app. 2). Resources for Research on Lewy Body available at http://www.fda.gov/ Dementia. AdvisoryCommittees/Calendar/ Dated: February 28, 2017. Date: April 7, 2017. default.htm. Scroll down to the Janice M. Soreth, Time: 8:00 a.m. to 6:00 p.m. appropriate advisory committee meeting Associate Commissioner for Special Medical Agenda: To review and evaluate grant link. Programs. applications. Procedure: Interested persons may [FR Doc. 2017–04152 Filed 3–2–17; 8:45 am] Place: National Institutes of Health, present data, information, or views, Neuroscience Center, 6001 Executive BILLING CODE 4164–01–P Boulevard, Rockville, MD 20852 (Virtual orally or in writing, on issues pending Meeting). before the committees. All electronic Contact Person: Ernest Lyons, Ph.D., and written submissions submitted to DEPARTMENT OF HEALTH AND Scientific Review Officer, Scientific Review the Docket (see the ADDRESSES section) HUMAN SERVICES Branch, NINDS/NIH/DHHS, Neuroscience on or before March 21, 2017, will be Center, 6001 Executive Blvd., Suite 3204, provided to the committees. Oral National Institutes of Health MSC 9529, Bethesda, MD 20892–9529, (301) presentations from the public will be 496–0182, lyonse@ninds.nih.gov. National Institute of Neurological Name of Committee: National Institute of scheduled between approximately 1 Disorders and Stroke; Notice of Closed Neurological Disorder and Stroke Special p.m. and 2 p.m. Those individuals Meetings Emphasis Panel; Training and Career interested in making formal oral Development Application Review. presentations should notify the contact Pursuant to section 10(d) of the Date: April 10, 2017. person and submit a brief statement of Federal Advisory Committee Act, as Time: 1:30 p.m. to 4:30 p.m. the general nature of the evidence or amended (5 U.S.C. App.), notice is Agenda: To review and evaluate grant arguments they wish to present, the hereby given of the following meetings. applications. names and addresses of proposed The meetings will be closed to the Place: National Institutes of Health, participants, and an indication of the public in accordance with the Neuroscience Center, 6001 Executive approximate time requested to make provisions set forth in sections Boulevard, Rockville, MD 20852 (Telephone their presentation on or before March 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Conference Call). 13, 2017. Time allotted for each as amended. The grant applications and Contact Person: Elizabeth A. Webber, Ph.D., Scientific Review Officer, Scientific presentation may be limited. If the the discussions could disclose mstockstill on DSK3G9T082PROD with NOTICES Review Branch, NINDS/NIH/DHHS, number of registrants requesting to confidential trade secrets or commercial Neuroscience Center, 6001 Executive Blvd., speak is greater than can be reasonably property such as patentable material, Suite 3204, MSC 9529, Bethesda, MD 20892– accommodated during the scheduled and personal information concerning 9529, (301) 496–1719, webbere@mail.nih.gov. open public hearing session, FDA may individuals associated with the grant (Catalogue of Federal Domestic Assistance conduct a lottery to determine the applications, the disclosure of which Program Nos. 93.853, Clinical Research speakers for the scheduled open public would constitute a clearly unwarranted Related to Neurological Disorders; 93.854, hearing session. The contact person will invasion of personal privacy. Biological Basis Research in the VerDate Sep<11>2014 16:42 Mar 02, 2017 Jkt 241001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\03MRN1.SGM 03MRN1

Federal Register / Vol. 82, No. 41 / Friday, March 3, 2017 / Notices 12459 Neurosciences, National Institutes of Health, Date: April 13, 2017. DEPARTMENT OF HEALTH AND HHS) Time: 2:00 p.m. to 4:00 p.m. HUMAN SERVICES Dated: February 27, 2017. Agenda: To review and evaluate grant Sylvia L. Neal, applications. National Institutes of Health Place: National Institutes of Health, Program Analyst, Office of Federal Advisory Committee Policy. National Institute on Alcohol Abuse and National Cancer Institute; Amended Alcoholism, 5635 Fishers Lane, Bethesda, Notice of Meeting [FR Doc. 2017–04078 Filed 3–2–17; 8:45 am] MD 20892 (Telephone Conference Call). BILLING CODE 4140–01–P Notice is hereby given of a change in Contact Person: Philippe Marmillot, Ph.D., the meeting of the National Cancer National Institutes of Health, National Institute Special Emphasis Panel, March Institute on Alcohol Abuse and Alcoholism, DEPARTMENT OF HEALTH AND 8, 2017, 12:00 p.m. to March 8, 2017, 5635 Fishers Lane, Rm 2017, Bethesda, MD HUMAN SERVICES 04:00 p.m., National Cancer Institute 20892, 301–443–2861, marmillotp@ Shady Grove, 9609 Medical Center National Institutes of Health mail.nih.gov. Drive, 7W110, Rockville, MD, 20850 (Catalogue of Federal Domestic Assistance which was published in the Federal National Cancer Institute; Amended Program Nos. 93.271, Alcohol Research Register on December 29, 2016, 81 FR Notice of Meeting Career Development Awards for Scientists 96029. and Clinicians; 93.272, Alcohol National The meeting notice is amended to Notice is hereby given of a change in Research Service Awards for Research change the date and time of the meeting the meeting of the National Cancer Training; 93.273, Alcohol Research Programs; to March 30, 2017 from 12:30 p.m. to Institute Board of Scientific Advisors, 93.891, Alcohol Research Center Grants; 4:00 p.m. The meeting is closed to the March 21, 2017, 8:30 a.m. to March 22, 93.701, ARRA Related Biomedical Research 2017, 12:00 p.m., National Institutes of public. and Research Support Awards, National Health, Building 31 Center Drive, Dated: February 27, 2017. Institutes of Health, HHS) Conference Room 6, Bethesda, MD Melanie J. Pantoja, 20892 which was published in the Dated: February 27, 2017. Program Analyst, Office of Federal Advisory Federal Register on February 22, 2017, Melanie J. Pantoja, Committee Policy. 82 FR 11363. Program Analyst, Office of Federal Advisory [FR Doc. 2017–04076 Filed 3–2–17; 8:45 am] The meeting notice is amended to Committee Policy. BILLING CODE 4140–01–P change the meeting date to March 21, [FR Doc. 2017–04077 Filed 3–2–17; 8:45 am] 2017. The location and time remain the BILLING CODE 4140–01–P same. The meeting is open to the public. DEPARTMENT OF HEALTH AND Dated: February 27, 2017. HUMAN SERVICES Melanie J. Pantoja, DEPARTMENT OF HEALTH AND Program Analyst, Office of Federal Advisory HUMAN SERVICES National Institutes of Health Committee Policy. [FR Doc. 2017–04074 Filed 3–2–17; 8:45 am] National Institutes of Health Center for Scientific Review; Notice of Closed Meetings BILLING CODE 4140–01–P National Cancer Institute; Amended Pursuant to section 10(d) of the Notice of Meeting Federal Advisory Committee Act, as DEPARTMENT OF HEALTH AND amended (5 U.S.C. App.), notice is HUMAN SERVICES Notice is hereby given of a change in hereby given of the following meetings. the meeting of the National Cancer The meetings will be closed to the National Institutes of Health Institute Special Emphasis Panel, March public in accordance with the National Institute on Alcohol Abuse 7, 2017, 12:00 p.m. to March 7, 2017, provisions set forth in sections and Alcoholism; Notice of Closed 4:00 p.m., National Cancer Institute 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Meeting Shady Grove, 9609 Medical Center as amended. The grant applications and Drive, 7W110, Rockville, MD, 20850 the discussions could disclose Pursuant to section 10(d) of the which was published in the Federal confidential trade secrets or commercial Federal Advisory Committee Act, as Register on December 29, 2016, 81 FR property such as patentable material, amended (5 U.S.C. App.), notice is 96029. and personal information concerning hereby given of the following meeting. individuals associated with the grant The meeting will be closed to the The meeting notice is amended to applications, the disclosure of which public in accordance with the change the date and time of the meeting would constitute a clearly unwarranted provisions set forth in sections to March 28, 2017 from 11:00 a.m. to invasion of personal privacy. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 2:00 p.m. The meeting is closed to the public. Name of Committee: Center for Scientific as amended. The grant applications and Review Special Emphasis Panel; Member the discussions could disclose Dated: February 27, 2017. Conflict: Genomics and Epigenomics Studies confidential trade secrets or commercial Melanie J. Pantoja, and Tools Development. property such as patentable material, Date: March 22, 2017. Program Analyst, Office of Federal Advisory Time: 1:00 p.m. to 4:00 p.m. and personal information concerning Committee Policy. Agenda: To review and evaluate grant individuals associated with the grant mstockstill on DSK3G9T082PROD with NOTICES [FR Doc. 2017–04075 Filed 3–2–17; 8:45 am] applications. applications, the disclosure of which Place: National Institutes of Health, 6701 would constitute a clearly unwarranted BILLING CODE 4140–01–P Rockledge Drive, Bethesda, MD 20892 invasion of personal privacy. (Telephone Conference Call). Name of Committee: National Institute on Contact Person: Methode Bacanamwo, Alcohol Abuse and Alcoholism Special Ph.D., Scientific Review Officer, Center for Emphasis Panel; AA–1 and AA–4 Conflict Scientific Review, National Institutes of Applications. Health, 6701 Rockledge Drive, Room 2200, VerDate Sep<11>2014 16:42 Mar 02, 2017 Jkt 241001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\03MRN1.SGM 03MRN1


Document Created: 2018-02-01 14:46:07
Document Modified: 2018-02-01 14:46:07
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 27-28, 2017.
FR Citation82 FR 12458 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR